TGA Australia Safety Alerts
GovPing monitors TGA Australia Safety Alerts for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 7 changes logged to date.
Thursday, April 16, 2026
Artri Ajo King Tablets Contain Undeclared Prescription Medicines
TGA Laboratory testing identified Artri Ajo King tablets as containing undeclared diclofenac and dexamethasone, both prescription-only medicines in Australia. The TGA has issued a safety advisory warning consumers to stop using the product and is coordinating with the Australian Border Force to seize and destroy shipments at the border. Supply of these products without declared prescription medicines is illegal under Australian therapeutic goods legislation.
Monday, April 13, 2026
Understanding Responsibilities When Importing, Compounding and Supplying Unapproved Peptide Products
TGA has published a safety advisory warning of rising import, supply, compounding and advertising of unapproved peptide products in Australia. Products containing BPC-157, GHK-Cu, TB-500, retatrutide, and CJC-1295 are specifically identified as unapproved goods not evaluated for safety, quality, or effectiveness. The TGA states it is actively monitoring this issue from both safety and law enforcement perspectives and reminds affected parties of their obligations under the Therapeutic Goods Act 1989.
Thursday, March 12, 2026
TGA Safety Alert: Natures Valley Collagen Builder contains undeclared sildenafil
The Therapeutic Goods Administration (TGA) has issued a safety alert regarding Natures Valley Collagen Builder tablets, which were found to contain undeclared sildenafil. Consumers are warned that the product poses a serious health risk and should not be taken.
TGA Safety Advisory: Counterfeit GLP-1 Weight Loss Products
The Therapeutic Goods Administration (TGA) has issued an updated safety advisory regarding counterfeit weight loss products falsely claiming to contain GLP-1 receptor agonists. Laboratory testing confirmed these products contain no active GLP-1 ingredients and are not included in the Australian Register of Therapeutic Goods.
Safety Concerns Over Imported Counterfeit Melatonin Products
The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding imported counterfeit unregistered melatonin products. Laboratory testing revealed significant discrepancies in melatonin content, with some products containing over 400% of the labelled amount and others none at all, posing serious risks to consumers, especially children.
TGA Safety Alert: Counterfeit Botox Vials Continue to be Imported
The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding the continued importation of counterfeit Botox vials into Australia. These products, packaged to appear genuine but confirmed as fake by AbbVie, pose significant public health risks and cannot be legally imported under any circumstances.
TGA Safety Alert: Ayurvedic Tablets Contain High Heavy Metals
The Therapeutic Goods Administration (TGA) has issued a safety alert regarding Kumar Kalyan Rasa tablets, an Ayurvedic medicine. Testing revealed extremely high concentrations of heavy metals, including mercury, lead, arsenic, and cadmium, posing serious health risks to consumers, particularly pregnant women and children. The TGA urges consumers to exercise extreme caution with such products.
Get daily alerts for TGA Australia Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source details
Activity
Browse Categories
Get TGA Australia Safety Alerts alerts
We'll email you when TGA Australia Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.